Effectiveness of cumulative glycemic control in T2DM patients who walk for moderate intensity aerobics exercise by using smart watch at Po Wai Primary Care Unit, Surat Thani Province
Keywords:
Type 2 diabetes mellitus patients, Smartwatch, Pedometer, Moderate-intensity aerobics exercise, HbA1cAbstract
Background : Current treatment guidelines for T2DM focus on educating patients and building self-care skills alongside medication. Researchers have chosen to incorporate smartwatch to increase physical activity, aiming to improve diabetes management outcomes.
Objective : This study investigated the outcomes and compared glycemic control in T2DM patients not using insulin, who engaged in moderate-intensity aerobic exercise with step counting using a smartwatch to achieve exercise goals, before and after a 12-week trial at the Po Wai Primary Care Unit, Surat Thani. The results can potentially be applied to community care.
Methods : This was a quasi-experimental study conducted from November 1, 2566, to March 30, 2567, involving 73 participants split into an experimental group of 24 and a control group of 49. Outcome measures included changes in HbA1c levels after completing the 12-week trial.
Result : There were no statistically significant differences (P > .05) between the experimental and control groups in terms of sex, age, BMI, waist circumference, and HbA1c levels. However, after completing the 12-week trial, within the experimental group, there were statistically significant decreases (P < .05) in mean HbA1c levels by 0.38 mg%, weight by 1.11 kg, and waist circumference by 1.05 cm. In contrast, the control group showed non-significant increases (P > .05) in these parameters. Comparing between groups, statistically significant differences (P < .01) were found in mean HbA1c levels, with the experimental group showing a lower average HbA1c level by 1.87 mg% (95% CI = -0.07 to 2.34, F = 55.79).
Conclusion : Moderate-intensity aerobic exercise using smartwatch to track steps significantly reduces HbA1c levels in T2DM patients not using insulin, compared to a control group instructed to maintain their usual lifestyle.
References
Magliano DJ BE. IDF Diabetes Atlas 2021 2021. Available from: https://diabetesatlas.org/idfawp/ resourcefiles/2021/07/IDF_Atlas_10th_Edition_2021.pdf.
ศาสตราจารย์นายแพทย์วิชัย เอกพลากร. การสำรวจสุขภาพประชาชนไทยโดยการตรวจร่างกายครั้งที่ 6 พ.ศ. 2562-2563. สำนักพิมพ์อักษรกราฟฟิคแอนด์ดีไซน์: คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล; 2564. Available from: https://kb.hsri.or.th/dspace/handle/11228/5425.
แนวทางเวชปฎิบัติสำหรับโรคเบาหวาน 2566. บริษัทศรีเมืองการพิมพ์ จำกัด: สมาคมโรคเบาหวานแห่งประเทศไทย, สมาคมต่อมไร้ท่อแห่งประเทศไทย; 2566. Available from: https://drive.google.com/file/d/1OAIDiCyGsJYA1-wTAxoOu6yL_YL9c7IG/view.
รองศาสตราจารย์แพทย์หญิงทิพาพร ธาระวานิช. มาตรฐานการให้ความรู้และการสนับสนุนการจัดการตนเอง พ.ศ. 2565. วารสารเบาหวาน ปีที่55 ฉบับที่1. 2566.
Neil-Sztramko SE, Gotay CC, Sabiston CM, Demers PA, Campbell KC. Feasibility of a telephone and web-based physical activity intervention for women shift workers. Transl Behav Med. 2017;7(2):268-76.
Shenoy S, Guglani R, Sandhu JS. Effectiveness of an aerobic walking program using heart rate monitor and pedometer on the parameters of diabetes control in Asian Indians with type 2 diabetes. Prim Care Diabetes. 2010;4(1):41-5.
Xiaomi ประเทศไทย. Redmi Smart Band 2 [Internet]. 2024[cited 2024 Jan 5]. Available from: https://www.mi.com/th/product/redmi-smart-band-2/specs
American Diabetes Association Professional Practice Committee; 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S39–S45.
Baskerville R, Ricci-Cabello I, Roberts N, Farmer A. Impact of accelerometer and pedometer use on physical activity and glycaemic control in people with Type 2 diabetes. Diabet Med. 2017 May;34(5):612-620.
Peng P, Zhang N, Huang J, Jiao X, Shen Y. Effectiveness of Wearable Activity Monitors on Metabolic Outcomes in Patients With Type 2 Diabetes. Endocr Pract. 2023 May;29(5):368-378.
Fayehun AF, Olowookere OO, Ogunbode AM, Adetunji AA, Esan A. Walking prescription of 10 000 steps per day in patients with type 2 diabetes mellitus. Br J Gen Pract. 2018 Feb;68(667):e139-e145.
Kooiman TJM, de Groot M, Hoogenberg K, Krijnen WP, van der Schans CP, Kooy A. Self-tracking of Physical Activity in People With Type 2 Diabetes. Comput Inform Nurs. 2018 Jul;36(7):340-349.
Xie J, Wen D, Liang L, Jia Y, Gao L, Lei J. Evaluating the Validity of Current Mainstream Wearable Devices in Fitness Tracking Under Various Physical Activities. JMIR Mhealth Uhealth. 2018 Apr 12;6(4):e94.
Bentley CL, Otesile O, Bacigalupo R, Elliott J, Noble H, Hawley MS, Williams EA, Cudd P. Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes. BMC Med Inform Decis Mak. 2016 Jul 15;16:92.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Region11Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
